Colorectal Cancer Clinical Trial
Official title:
Towards Painless Colonoscopy: a Dedicated Training to Decrease the Rate of Painful Colonoscopy - a Randomized Controlled Trial
One of the major barriers to CRC screening participation is a negative perception of
colonoscopy as a painful and unpleasant procedure. Previously, by monitoring patient-reported
outcomes as one of the colonoscopy quality performance measures, the investigators identified
the endoscopist as the single, most important risk factor for painful colonoscopy. Therefore,
the investigators propose a randomized controlled trial to analyse the effectiveness of
directed training on the endoscopists painful colonoscopy rate.
The study will be conducted in two phases: endoscopist categorization and design of training
(I) and randomized controlled trial evaluating training effectiveness (II).
Phase I will include endoscopists from Polish Colonoscopy Screening Programme (PCSP) willing
to participate. Volunteers will be divided into underperformers, average performers and
overperformers, based on their painful colonoscopy rate (obtained from PCSP database records)
and will be invited to take part in the initial workshop focused on pain reduction during
colonoscopy (conducted in a similar fashion to Train Colonoscopy Leaders (TCL) workshop,
aiming at ADR improvement).
On the basis of the differences in performance between over- and underperformers, categories
of importance, target scores and a questionnaire for the assessment of factors for
improvement will be developed.
In Phase II, endoscopists from PCSP screening centres previously categorized as
underperformers and average performers will be randomized in 1:1 ratio either to control (no
intervention) or intervention arm.
The subjects in the control arm will not be trained or informed about study participation.
The endoscopists assigned to the intervention arm will be invited to take part in one
training session designed in Phase I of the study (according to the evaluation questionnaire
from Phase I). Willing overperformers will be asked to participate in the training as
teachers. The training session will be divided into two parts: theoretical - presentation of
research on painless colonoscopy - and practical - colonoscopy performance with commentary.
Subjects matched 1:1 with trainers will take part in such a session, supervised by the study
coordinator.
Each endoscopist who underwent training in the second phase of the study will be sent a
written, customized feedback on changes after the intervention and information about factors
to improve (as per evaluation questionnaire from Phase I of the study). All endoscopists
enrolled into Phase II will be followed through PCSP database for the endpoint of painful
colonoscopy rate; the intervention arm will be compared with the control group at 6 and 12
months after feedback in order to investigate whether the adjusted painful colonoscopy rate
improved as a result of the intervention.
Background and study rationale:
Colorectal cancer (CRC) is the second leading cause of death from cancer in Europe. Several
modalities of CRC screening exist, with each screening modality including colonoscopy either
as a primary or secondary test (following positive sigmoidoscopy or faecal occult blood
test). Unfortunately, patients perceive colonoscopy as a painful and unpleasant procedure.
This is one of the major barriers for participation in CRC screening, particularly since
those being screened are usually healthy and asymptomatic. Monitoring patient-reported
outcomes is one of the understudied performance measures for quality in colonoscopy according
to recent guidelines.
Since 2014, the Polish Colorectal Cancer Screening Programme (PCSP) has routinely used the
Gastronet questionnaire to measure patient-reported outcomes. The Gastronet is a Norwegian
quality-assurance programme that was initiated in 2003. Patients fill in the questionnaire at
home 1 day after colonoscopy and send it back via traditional mail. Questions on pain are
answered on a 4-point scale: no pain, slight pain, moderate pain, and severe pain. This scale
has been validated previously.
In previous analysis, the investigators have identified several, independent risk factors for
painful colonoscopy. However, the single, most important risk factor for painful colonoscopy
was the endoscopist himself. This was shown with regards to pain rates adjusted for all
factors found relevant in multivariate models (including sedation). The variation among
endoscopists was observed as 11- to 23-fold difference in adjusted painful colonoscopy rate.
Adjusting for most measurable variables allowed us to cancel the effect of patient selection
or other technical issues (endoscope used etc.) and attribute the observed differences, with
high probability, to the individual, unquantifiable technical and nontechnical skills
possessed by each endoscopist. These skills comprise both the interpersonal skills required
to establish a meaningful patient-endoscopist relationship and individual manual skills.
Among modifiable factors, propofol sedation resulted in better procedure tolerance. In most
countries, the propofol sedation must be performed by an anaesthesiologist. This practice
generates higher costs and reduces colonoscopy unit capacity, as it requires more time,
resources, and personnel. Moreover, sedated colonoscopy poses a greater risk of
sedation-related (e.g., pneumonia and cardiovascular events) and procedure-related (e.g.,
bowel perforation and bleeding) complications. What was surprising, sedation based on
combination of opioids and benzodiazepines (regarded devoid of aforementioned downsides of
propofol sedation) did not improve colonoscopy tolerance in comparison to no sedation at all.
This observation led us to suggesting that only propofol sedation should be regarded as
effective in case of colonoscopy.
Taking into account the fact that propofol sedation is not a universal and ultimate remedy to
increase colonoscopy satisfaction, directed training should be considered to reduce the rate
of painful colonoscopies. Technical and nontechnical skills can be either improved or
developed with such training, which should focus not only on reducing the odds for pain
during, but also after colonoscopy. Such training is necessary especially in cases of
countries with limited colonoscopy and/or anaesthesia services capacity.
Up to date, there are no studies assessing the efficacy of training, aiming at reducing the
odds of painful colonoscopy. Moreover, there is no existing data on how such training should
be designed. Therefore the investigators propose a two-step study:
1. to design a dedicated training program and
2. to evaluate effectiveness of such training in a randomized controlled trial.
Hypothesis:
Dedicated training reduces the painful colonoscopy rate.
Aim:
To investigate, whether directed training leads to reduction in painful colonoscopy rate.
Methods:
The study will be conducted in two phases:
I. Endoscopist categorization based on their performance with regards to colonoscopy pain
(under- over- and average performers), according to feedback provided for colonoscopies
before study entry and design of training II. Randomized controlled trial evaluating training
effectiveness. Phase I - training (intervention) design The first phase of the study consists
of the endoscopist categorization, observation of work and workshop with selected PCSP
endoscopists to design the training program.
First of all, to categorize endoscopists, the investigators will build multivariate models
(as in our previous work) for dataset from years 2014-2018 for pain during endoscopy,
allowing us to divide endoscopists into three categories:
1. Underperformers: endoscopists performing worse than expected (with adjusted painful
colonoscopy rate higher than mean).
2. Overperformers: endoscopists performing better than expected (with adjusted painful
colonoscopy rate lower than mean).
3. Average performers: endoscopists performing inside the confidence interval for mean
adjusted painful colonoscopy rate.
For the purpose of creating dedicated assessment questionnaire, the investigators will adapt
existing DOPS questionnaire, with tailored modifications (utilising such categories as loop
formation and loop reduction, going through flexures, time to caecum, utilisation of
additional techniques (change of position, assistance), non-technical skills (communicating
with a patient), time slot for colonoscopy, equipment, assistant involvement, sedation etc.)
based on experts' opinions, working in PCSP coordinating centre. First, each expert
endoscopist will be asked to suggest 5 key, specific elements that are crucial for painless
colonoscopy. These elements will be compiled into one list and divided into appropriate
domains (pre-procedure, technical considerations, non-technical skills, infrastructure,
etc.). The elements will be formatted into questions with binary answer (yes/no). Next, the
investigators will perform visits at willing sites, where screening colonoscopies are done by
up to 5 under- or overperformers. During such visits, endoscopists will be assessed during
their routine work, in friendly environment, utilising the questionnaire, however the purpose
of the visits is to modify the questionnaire, to include aspects not initially covered.
Phase II - randomized controlled trial The second phase of the study consists of the
randomized controlled trial evaluating the effectiveness of the training developed in Phase
I, based on constructed questionnaire. Endoscopists previously categorized as underperformers
and average performers from PCSP screening centres will be randomized in 1:1 ratio either to
control arm (practice as usual) or training intervention arm. Overperformers will be asked to
participate in training sessions as regular participants, however overperformers will not be
randomized and treated as study subjects; after intervention, they will be informed about the
study design and training session purpose. The endoscopists assigned to the training
intervention group will be invited to take part in one training session, similar to the one
introduced in Train Colonoscopy Leaders trial (evaluation questionnaire from Phase I will be
used). After the training session, each endoscopist from the intervention arm will be sent a
written report, including customized feedback on performance and suggested areas of
improvement (on the basis of evaluation questionnaire from Phase I of the study).
Endoscopists from the intervention group will be followed through PCSP database and will be
compared with the control group at 6 and 12 months after feedback. Endoscopists from the
control group will not be trained nor will they be informed about study participation. They
will receive a reminder, that dedicated report on painful colonoscopy rate is provided in the
PCSP database and they will be monitored for endpoints through PCSP database.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |